Prophylactic and therapeutic vaccination against a mucosal papillomavirus

References

1. Campo M. S. 1991; Vaccination against papillomavirus. Cancer Cells 3:421–426
   [Google Scholar]
2. Campo M. S., Jarrett W. F. H. 1986; Papillomavirus infection in cattle: viral and chemical cofactors in naturally occurring and experimentally induced tumours. In Papillomaviruses: Ciba Foundation Symposium 120 pp. 117–135 Edited by Evered D., Clark S. New York: John Wiley;
   [Google Scholar]
3. Campo M. S., Moar M. H., Jarrett W. F. H., Laird H. M. 1980; A new papillomavirus associated with alimentary cancer in cattle. Nature, London 286:180–182
   [Google Scholar]
4. Chen L., Thomas E. K., Hu S.-L., Hellstrom I., Hellstrom K. E. 1991; Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proceedings of the National Academy of Sciences, U.S.A. 88:110–114
   [Google Scholar]
5. Christensen N. D., Kreider J. W., Kan N. C., DiAngelo S. L. 1991; The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes. Virology 181:572–579
   [Google Scholar]
6. de Villiers E.-M. 1989; Heterogeneity of the human papillomavirus group. Journal of Virology 63:4898–4903
   [Google Scholar]
7. Dollard S. C., Wilson J. L., Demeret L. M., Bonnez W., Reichman R. C., Broker T. R., Chow L. T. 1992; Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes and Development 6:1131–1142
   [Google Scholar]
8. Evans C. A., Gorman L. R., Ito Y., Weiser R. S. 1962; Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines. Journal of the National Cancer Institute 29:277–285
   [Google Scholar]
9. Ghim S.-J., Jenson A. B., Schlegel R. 1992; HPV-1 LI protein expressed in COS cells displays conformational epitopes found on intact virions. Virology 190:548–552
   [Google Scholar]
10. Jackson M. E., Pennie W. D., McCaffery R. E., Smith K. T., Grindlay G. J., Campo M. S. 1991; The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Molecular Carcinogenesis 4:382–387
    [Google Scholar]
11. Jaggar R. T., Pennie W. D., Smith K. T., Jackson M. E., Campo M. S. 1990; Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. Journal of General Virology 71:3041–3046
    [Google Scholar]
12. Jarrett W. F. H. 1985; The natural history of bovine papillomavirus infection. In Advances in Viral Oncology vol. 5 pp. 83–102 Edited by Klein G. New York: Raven Press;
    [Google Scholar]
13. Jarrett W. F. H., Campo M. S., O’Neil B. W., Laird H. M., Coggins L. W. 1984; A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new subgroup. Virology 136:255–264
    [Google Scholar]
14. Jarrett W. F. H., O’Neil B. W., Gaukroger J. M., Smith K. T., Laird H. M., Campo M. S. 1990a; Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Veterinary Record 126:473–475
    [Google Scholar]
15. Jarrett W. F. H., O’Neil B. W., Gaukroger J. M., Laird H. M., Smith K. T., Campo M. S. 1990b; Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination. Veterinary Record 126:449–452
    [Google Scholar]
16. Jarrett W. F. H., Smith K. T., O’Neil B. W., Gaukroger J. M., Chandrachud L. M., Grindlay G. J., McGarvie G. M., Campo M. S. 1991; Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184:33–42
    [Google Scholar]
17. Jenison S. A., Firzlaff J. M., Langenberg A., Galloway D. A. 1988; Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coff-expressed fusion proteins. Journal of Virology 62:2115–2123
    [Google Scholar]
18. Kreider J. W., Howett M. K., Lill N. L., Bartlett G. L., Zaino R. J., Sedlacek T. V., Mortel R. 1986; In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata. Journal of Virology 59:369–376
    [Google Scholar]
19. Lin Y.-L., Borenstein L. A., Selvakumar R., Ahmed R., Wettstein F. O. 1992; Effective vaccination against papilloma development by immunization with LI or L2 structural proteins of cottontail rabbit papillomavirus. Virology 187:612–619
    [Google Scholar]
20. McLean C. S., Sterling J. S., Mowat J., Nash A. A., Stanley M. A. 1993; Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. Journal of General Virology 74:239–245
    [Google Scholar]
21. Meneguzzi G., Cerni C., Kieny M. P., Lathe R. 1991; Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology 181:62–69
    [Google Scholar]
22. Meyers C., Frattini M. G., Hudson J. B., Laimins L. A. 1992; Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971–973
    [Google Scholar]
23. Olson C., Segre D., Skidmore L. V. 1959; Further observations on immunity to bovine cutaneous papillomatosis. American Journal of Veterinary Research 21:233–242
    [Google Scholar]
24. Pennie W. D., Grindlay G. J., Cairney M., Campo M. S. 1993; Analysis of the transforming functions of bovine papillomavirus type 4. Virology 193:614–620
    [Google Scholar]
25. Ruther U., Muller-Hill B. 1983; Easy identification of cDNA clones. EMBO Journal 2:1791–1794
    [Google Scholar]
26. Smith B. D., Johnson K. S. 1988; Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene 67:31–40
    [Google Scholar]
27. Stacey S. N., Bartholomew J. S., Ghosh A., Stern P. L., Mackett M., Arrand J. R. 1992; Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus for use and detection of anti-E6 antibodies in human sera. Journal of General Virology 73:2337–2345
    [Google Scholar]
28. Steinberg B. M. 1987; Laryngeal papillomas. Clinical aspects and in vitro studies. In The Papovaviridae vol 2 pp. 265–292 Edited by Salzman N. P., Howley P. M. New York: Plenum Press;
    [Google Scholar]
29. Sterling J., Stanley M., Gatward G., Minson T. 1990; Production of human papillomavirus type 16 virions in a keratinocyte cell line. Journal of Virology 64:6305–6307
    [Google Scholar]
30. Teichman L. B., LaPorta R. F. 1987; The expression of papillomaviruses in epithelial cells. In The Papovaviridae vol. 2 pp. 109–139 Edited by Salzman N. P., Howley P. M. New York: Plenum Press;
    [Google Scholar]
31. Tindle R. W., Smith J. A., Geysen H. M., Selvey L. A., Frazer I. H. 1990; Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. Journal of General Virology 71:1347–1354
    [Google Scholar]
32. zur Hausen H. 1991; Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9–13
    [Google Scholar]